Open-house biologics rebate agreement for Epoetin beta
Original notice title
Germany – Pharmaceutical products – Open-House-Biologika-Rabattverträge 2025-39 - Epoetin beta
Opportunity Score
Why this score?
Opportunity
52 / 100
Complexity
58 / 100
Risk factors
The notice contains two different end-time references: structured data gives 2028-01-30 22:59:59 UTC, while the XML not...
Participation is limited to pharmaceutical undertakings meeting the AMG and authorisation conditions for the specific p...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- Supplies contract
- 1 lot
- Duration until Jan 2028
- Supply-related pharmaceutical rebate agreement for Epoetin beta.
- Open-house arrangement with uniform contractual conditions for all eligible participants.
Show full summary
Open-house pharmaceutical supply arrangement for Epoetin beta in Germany, led by Techniker Krankenkasse with HEK and hkk as participating buyers. The notice states that any suitable pharmaceutical undertaking may join during the contract period, subject to the stated legal and self-declaration requirements. No contract value is provided. Submission is not via the portal; contracts must be sent by email with qualified electronic signature or by post, and the documents are only available electronically. The notice is in German and the extracted TED XML notice was analyzed, but no separate procurement document text was provided.
Risks
The notice contains two different end-time references: structured data gives 2028-01-30 22:59:59 UTC, while the XML not...
Participation is limited to pharmaceutical undertakings meeting the AMG and authorisation conditions for the specific p...
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Applicant must be a pharmaceutical undertaking within the meaning of Section 4(18) AMG for the offered medicinal product(s).
- Applicant must have its seat in the AMG territory, another EU Member State, or another EEA state.
- Applicant must hold a valid marketing authorisation for the relevant medicinal product(s), or otherwise be entitled to place them on the market in its own name.
Buyer
Location
Hamburg, DEU
Website
Identifier
992-80116-93
Activity
Health
Lots (1)
LOT-0001
Open-house biologics rebate agreement for Epoetin beta
Open-house contract for pharmaceutical rebate agreements under Section 130c(1) SGB V for the active substance Epoetin beta. The lot covers nationwide performance in Germany and is described as an open-house procedure with uniform conditions, no individual negotiations, and no exclusivity. The lot information comes from structured data and the TED XML notice.
Location
Duration
Category
Deadline
Award details
Ziel ist der Abschluss von Arzneimittelrabattverträgen nach § 130c Abs. 1 SGB V zu dem Wirkstoff Epoetin beta im Rahmen eines Open-House-Verfahrens.
Value note
Show original TED data
Original lot title
Open-House-Biologika-Rabattverträge 2025-39 - Epoetin beta
Original TED description
Ziel ist der Abschluss von Arzneimittelrabattverträgen nach § 130c Abs. 1 SGB V zu dem Wirkstoff Epoetin beta im Rahmen eines Open-House-Verfahrens.
Procurement Details
- Publication date
- 03 Dec 2025
- Languages
- German
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 803675-2025
Documents (1)
Similar tenders
Germany – Site preparation work – VE111 Baustelleneinrichtung (119VM514 / Kronsh,SanDstBw,Ersatzneub. ZInstSanBw)
Poland – Advertising and marketing services – Zaplanowanie i realizacja kampanii Ministerstwa Finansów z zakresu działalności resortu finansów
France – Insurance services – Prestations de services d'assurance pour groupement le groupement hospitalier de territoire Yvelines Nord
Finland – Architectural, construction, engineering and inspection services – Tietomallikoordinaattori-, inventointimittaus- ja mallinnuspalvelujen puitejärjestely 2026-2028 (2028-2030)
Greece – Cultural event organisation services – ΛΕΙΤΟΥΡΓΙΑ ΤΟΥ ΘΕΑΤΡΟΥ ΟΛΥΜΠΙΑ ΜΑΡΙΑ ΚΑΛΛΑΣ ΜΕ ΕΞΕΙΔΙΚΕΥΜΕΝΟ ΠΡΟΣΩΠΙΚΟ
Spain – Architectural, construction, engineering and inspection services – Redacción del Proyecto Básico y de Ejecución, Redacción del Estudio de Seguridad y Salud y Dirección de Obra para la construcción del I.E.S. Nº 1 de 12+0 uds. (Fase 1) en la urbanización El Bosque de Pioz (Guadalajara).
Opportunity Score
Why this score?
Opportunity
52 / 100
Complexity
58 / 100
Risk factors
The notice contains two different end-time references: structured data gives 2028-01-30 22:59:59 UTC, while the XML not...
Participation is limited to pharmaceutical undertakings meeting the AMG and authorisation conditions for the specific p...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications